CIR and 95% CI stratified by post-transplantation HCMV pp65-antigenemia and disease stage. (A) CIR by post-transplantation pp65-antigenemia of patients transplanted in first remission (P < .002). (B) CIR by post-transplantation pp65-antigenemia of patients transplanted after first remission (P < .0001). Tick marks indicate patients surviving free of relapse or competing events.